Skip to content

Stress Tracking and Symptom Evaluation in Depression (SENSE-D)

Stress Tracking and Symptom Evaluation in Depression (SENSE-D) - SENSE-D

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57936
Enrollment
50
Registered
2025-03-10
Start date
2026-01-15
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder Depression

Interventions

None listed

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a participant must meet the following criteria: Moderate to severe depression  Score = 26 on the Inventory of Depressive Symptoms-Self Report (IDS-SR)  Starting new treatment for major depressive disorder with rTMS, psychotherapy and/or antidepressants within the next month  Psychotherapy may include Cognitive Behavioral Therapy (CBT), Behavioral Activation Therapy, Interpersonal Therapy (IPT), Acceptance and Commitment Therapy (ACT), Psychodynamic Therapy, Life Review Therapy, Mindfulness-Based Cognitive Behavioral Therapy (MCBT)  

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: Primary diagnosis of post-traumatic stress disorder (PTSD) or Acute Stress Disorder (ASD)  Lifetime diagnosis of borderline personality disorder (BPD)  Other lifetime severe psychiatric comorbidity (e.g. bipolar disorder, schizophrenia) or current alcohol/drug dependence that requires clinical attention. Not fluent in Dutch 

Design outcomes

Primary

MeasureTime frame
Our main study parameter is feasibility evaluation via drop-out rates, study adherence, data coverage/completeness, and participant experiences and feedback.  

Secondary

MeasureTime frame
Our secondary study parameters is the evaluation of changes in the toolkit ingredients (surveys, cognitive tasks, passively collected data) and key mental health outcomes (depression severity via the IDS-SR and anxiety severity via the GAD-7). 

Countries

Netherlands

Contacts

Public ContactF Lamers

Amsterdam UMC

f.lamers@amsterdamumc.nlnvt

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 20, 2026